Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

Who May Qualify: - Undergoing uncomplicated cataract surgery with or without a posterior chamber intraocular lens (IOL) implantation. - If a contact lens is used for correction of post-operative aphakia, it must be a silicone elastomer lens or a rigid gas permeable lens (no water content). - Other protocol-specified inclusion criteria may apply. Who Should NOT Join This Trial: - Presence of clinically significant gastrointestinal, cardiovascular, hepatic, renal, hematological, endocrine, neurological, psychiatric, respiratory, or other medical condition that could increase the risk to the subject as determined by the investigator. - Has a post-traumatic cataract. - Presence of active or suspected viral, bacterial, or fungal disease in the study eye. - Ocular hypertension with an IOP in the study eye \>25 mmHg at Screening with or without treatment with anti-glaucoma monotherapy. - Subjects who have received a periocular corticosteroid injection in the study eye in the 3 months prior to Screening. - Subjects who have received any intravitreal corticosteroid delivery vehicle (eg, Retisert®, Ozurdex®, Iluvien®) in the study eye at any time. - Other protocol-specified exclusion criteria may apply Always talk to your doctor about whether this trial is right for you.